Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
1.890
+0.230 (13.86%)
At close: Mar 31, 2026
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $52.34 million as of March 31, 2026. Its market cap has increased by 905.89% in one year.
Market Cap
52.34M
Enterprise Value
50.59M
Revenue
38.73M
Ranking
n/a
PE Ratio
2.10
Stock Price
$1.89
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 52.34M, a decrease of -76.42%. That is a compound annual growth rate of -5.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 52.34M | 860.71% |
| Dec 31, 2025 | 5.45M | -54.11% |
| Dec 31, 2024 | 11.87M | 152.98% |
| Dec 29, 2023 | 4.69M | 5.76% |
| Dec 30, 2022 | 4.44M | -85.77% |
| Dec 31, 2021 | 31.18M | 145.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Global Cord Blood | 133.91M |
| Bioqual | 33.55M |
| Longduoduo Company | 15.31M |
| Aspira Women's Health | 15.22M |
| Psychemedics | 9.78M |
| Stella Diagnostics | 4.82M |
| Hypha Labs | 3.33M |
| Centogene | 3.28M |